Last reviewed · How we verify
Synbiotic Supplement
At a glance
| Generic name | Synbiotic Supplement |
|---|---|
| Also known as | Probio-Tec® ABCG-Stick-25, NOBEL (NBL) Probiotic Optima |
| Sponsor | Sheppard Pratt Health System |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome (NA)
- Human Milk Oligosaccharide-Based Synbiotic Supplement for Intestinal Microbiota Dysbiosis (EARLY_PHASE1)
- A Trial to Assess the Pharmacokinetics and Pharmacodynamics of a Novel Synbiotic Oral Supplement for Vaginal Health (NA)
- Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer (NA)
- Exploratory Study on a Multi-nutrient Supplement and Exercise Program for Improving Health Markers Associated to Longevity in Pre-frail Adults (NA)
- The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals With Excessive Body Weight (NA)
- Microbiological and Clinical Effects of Pre- and Probiotics in Non-Surgical Periodontal Therapy (NA)
- Synbiotic Supplementation and Inflammation in Predialysis Chronic Kidney Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Synbiotic Supplement CI brief — competitive landscape report
- Synbiotic Supplement updates RSS · CI watch RSS
- Sheppard Pratt Health System portfolio CI